We are still not seeing any big ramp up in orders through our channel checks in the semi-con sector and now believe that the much anticipated acceleration in orders will likely occur from 2-3Q25 onwards.
Positive 2H24 outlook
We still expect Frencken's profitability to be stronger in 2H24 vs 1H24 but earnings likely won’t be as strong as anticipated due to slower-than expected growth in the life science sector. Hence, we cut our FY24/25E PATMI forecast for Frencken by 15%/18% respectively, and lower our Frencken's target price to S$1.54, pegged to an unchanged 15.5x FY24E P/E.
- Read this at SGinvestors.io -
Semi-con ramp up likely delayed to 2-3Q25
- Read this at SGinvestors.io -
However, we believe the much anticipated ramp up in orders will now likely only come in 2Q/3Q25 as we do not see any signs of incoming ramp up yet from our channel checks.
Life science growth likely slower than expected
Read more at SGinvestors.io.
Above is an excerpt from a report by Maybank Research. Clients of Maybank Securities may be the first to access the full PDF report @ https://www.maybanktrade.com.sg/.
Use Trust Referral Code PGKPSWAE to sign up NTUC Link or Trust Link Credit Card or open a Trust Bank savings account this December: ✨Earn up to S$1,000 cashback reward 🎟 and win an XPENG G6 SUV 🚙 !